13,14-Dihydro-15-keto Prostaglandin F2α

13,14-Dihydro-15-keto Prostaglandin F2α (13,14-Dihydro-15-keto-PGF2α) is an endogenous metabolite present in Blood that can be used for the research of Pregnancy[1][2].

Product Specifications

CAS Number

[27376-76-7]

Product Name Alternative

13,14-Dihydro-15-keto-PGF2α

UNSPSC

12352211

Hazard Statement

H302, H312, H332

Target

Endogenous Metabolite

Type

Natural Products

Related Pathways

Metabolic Enzyme/Protease

Applications

Metabolism-protein/nucleotide metabolism

Field of Research

Others

Assay Protocol

https://www.medchemexpress.com/13-14-dihydro-15-keto-prostaglandin-f2α.html

Concentration

28.21 mM * 100 μL in Methyl acetate

Purity

99.0

Smiles

CCCCCC(CC[C@@H]1[C@H]([C@@H](O)C[C@H]1O)C/C=C\CCCC(O)=O)=O

Molecular Formula

C20H34O5

Molecular Weight

354.48

Precautions

H302, H312, H332

References & Citations

[1]The dynamic changes of several reproductive hormones during termination of early pregnancy by RU486 in combination with PG-05 in Chinese women. Adv Contracept. 1988 Dec;4 (4) :319-26. |[2]Lee N, et al. Endogenous toxic metabolites and implications in cancer therapy. Oncogene. 2020 Aug;39 (35) :5709-5720.